Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Dahl Andrew M., VP Senior. Insider active across 1 company, notably Edwards Lifesciences Corp. In total, 8 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €42k. Activity tracked since 13 September 2024. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Andrew M. Dahl serves as Senior Vice President and Corporate Controller at Edwards Lifesciences Corp. He is responsible for overseeing financial functions and ensuring compliance with accounting standards. His role is crucial for ensuring transparency and financial accountability within the company.